Shell Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,252
| Closed | -$49K | – | 1480 |
|
|
2020
Q3 | $49K | Hold |
5,252
| – | – | ﹤0.01% | 1272 |
|
|
2020
Q2 | $40K | Buy |
+5,252
| New | +$40.2K | ﹤0.01% | 1294 |
|
|
2019
Q2 | – | Sell |
-7,483
| Closed | -$96K | – | 1264 |
|
|
2019
Q1 | $96K | Hold |
7,483
| – | – | ﹤0.01% | 1154 |
|
|
2018
Q4 | $114K | Sell |
7,483
-600
| -7% | -$11.4K | ﹤0.01% | 1086 |
|
|
2018
Q3 | $162K | Hold |
8,083
| – | – | ﹤0.01% | 1111 |
|
|
2018
Q2 | $158K | Sell |
8,083
-458
| -5% | -$10.1K | ﹤0.01% | 1059 |
|
|
2018
Q1 | $172K | Hold |
8,541
| – | – | ﹤0.01% | 1057 |
|
|
2017
Q4 | $113K | Sell |
8,541
-25,952
| -75% | -$391K | ﹤0.01% | 1068 |
|
|
2017
Q3 | $636K | Buy |
+34,493
| New | +$643K | 0.01% | 767 |
|
|
2017
Q1 | – | Sell |
-24,169
| Closed | -$841K | – | 1109 |
|
|
2016
Q4 | $841K | Sell |
24,169
-211
| -0.9% | -$6.3K | 0.02% | 732 |
|
|
2016
Q3 | $598K | Buy |
+24,380
| New | +$609K | 0.01% | 801 |
|
Shell Asset Management's AMAG Position: Q4 2020 in Review
Shell Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 5,252 shares — an estimated $49K sold.
Shell Asset Management first reported a position in AMAG in Q3 2016 and held it in 11 quarters. The position peaked at $841K in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Shell Asset Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Shell Asset Management sold 5,252 AMAG Pharmaceuticals shares in Q4 2020, an estimated $49K.
- Shell Asset Management first reported a position in AMAG Pharmaceuticals in Q3 2016 and held it in 11 quarters.
- Shell Asset Management's AMAG Pharmaceuticals position peaked at $841K in Q4 2016.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Shell Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.